Sprycel Approved to Treat Rare Leukemia
Links shared publicly online about this topic
Sprycel Approval Expanded to Include Rare Leukemia - Drugs.com MedNews
drugs.com — “Sprycel (dasatinib) has received an additional approval from the U.S. Food and Drug Administration to treat a rare form of blood cancer called Philadelphia chro” View full resource at drugs.com
Most Recently Shared on October 28, 2010 at 9:06 pm By:
Drugs and Devices OW OW Health
Sprycel Approval Expanded to Include Rare Leukemia: THURSDAY, Oct. 28 -- Sprycel (dasatinib) has received an ... http://bit.ly/9fd3wo #drug
FDA approves additional medical indication for Sprycel
drugs.com — “Sprycel (dasatinib) is now approved to treat newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. Includes Sprycel side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 28, 2010 at 10:35 pm By:
FDA approves additional medical indication for Sprycel - http://bit.ly/cudetK
FDA approves additional medical indication for Sprycel
drugs.com — “Sprycel (dasatinib) is now approved to treat newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. Includes Sprycel side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 28, 2010 at 11:24 pm By:
Drugs and Devices OW OW Health
FDA approves additional medical indication for Sprycel: SILVER SPRING, Md., Oct. 28 - The U.S. Food and Drug ... http://bit.ly/cA1b5e #drug
Sprycel holds hope for treating Src dependent ovarian cancer
news-medical.net — “The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.” View full resource at news-medical.net
Most Recently Shared on November 11, 2009 at 10:15 am By:
Ovarian Cancer News: Sprycel holds hope for treating Src dependent ovarian cancer: The drug.. http://chilp.it/?94ceb2
FDA Approves Additional Medical Indication for Sprycel - Drugs.com MedNews
drugs.com — “Patients with rare type of leukemia now have another treatment option The U.S. Food and Drug Administration today approved a new indication for Sprycel (dasatin” View full resource at drugs.com
Most Recently Shared on October 29, 2010 at 1:16 pm By:
Drugs and Devices OW OW Health
FDA Approves Additional Medical Indication for Sprycel: Patients with rare type of leukemia now have another ... http://bit.ly/c4kBZd #drug
FDA Approves Adcetris To Treat Two Types Of Lymphoma
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).” View full resource at medicalnewstoday.com
Most Recently Shared on August 20, 2011 at 7:05 am By:
FDA Approves Adcetris To Treat Two Types Of Lymphoma http://mnt.to/3Z5T #lymphoma #leukemia
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
